Abstract
Smoking marijuana or administration of its main active constituent, Δ9-tetrahydrocannabinol (Δ9-THC), may exert potent dilating effects on human airways1,2,3,4. But the physiological significance of this observation and its potential therapeutic value are obscured by the fact that some asthmatic patients respond to these compounds with a paradoxical bronchospasm3,5. The mechanisms underlying these contrasting responses remain unresolved. Here we show that the endogenous cannabinoid anandamide exerts dual effects on bronchial responsiveness in rodents: it strongly inhibits bronchospasm and cough evoked by the chemical irritant, capsaicin, but causes bronchospasm when the constricting tone exerted by the vagus nerve is removed. Both effects are mediated through peripheral CB1 cannabinoid receptors found on axon terminals of airway nerves. Biochemical analyses indicate that anandamide is synthesized in lung tissue on calcium-ion stimulation, suggesting that locally generated anandamide participates in the intrinsic control of airway responsiveness. In support of this conclusion, the CB1 antagonist SR141716A enhances capsaicin-evoked bronchospasm and cough. Our results may account for the contrasting bronchial actions of cannabis-like drugs in humans, and provide a framework for the development of more selective cannabinoid-based agents for the treatment of respiratory pathologies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vachon, L., Fitzgerald, M. X., Solliday, N. H., Gould, I. A. & Gaensler, E. A. Single-dose effects of marihuana smoke. Bronchial dynamics and respiratory-center sensitivity in normal subjects. New Engl. J. Med. 288, 985– 989 (1973).
Tashkin, D. P., Shapiro, B. J., Lee, Y. E. & Harper, C. E. Effects of smoked marijuana in experimentally induced asthma. Am. Rev. Respir. Dis. 112, 377–386 (1975).
Tashkin, D. P. et al. Bronchial effects of aerosolized delta 9-tetrahydrocannabinol in healthy and asthmatic subjects. Am. Rev. Respir. Dis. 115, 57–65 (1977).
Iversen, L. L. The Science of Marijuana (Oxford Univ. Press, Oxford, 2000).
Abboud, R. T. & Sanders, H. D. Effect of oral administration of delta-9-tetrahydrocannabinol on airway mechanics in normal and asthmatic subjects. Chest 70, 480– 485 (1976).
Devane, W. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946 –1949 (1992).
Di Marzo, V. et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686– 691 (1994).
Szallasi, A. & Blumberg, P. M. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol. Rev. 51, 159– 212 (1999).
Barnes, P. J. Modulation of neurotransmission in airways. Physiol. Rev. 72, 699–729 (1992).
Rinaldi-Carmona, M. et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350, 240 –244 (1994).
Rinaldi-Carmona, M. et al. SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284, 644–650 (1998).
Calignano, A., La Rana, G., Giuffrida, A. & Piomelli, D. Control of pain initiation by endogenous cannabinoids. Nature 394, 277–281 (1998).
Karlsson, J. -A. & Fuller, R. W. Pharmacological regulation of the cough reflex—from experimental models to antitussive effects in man. Pulmonary Pharmacol. Ther. 12, 215–228 (1999).
Widdicombe, J. G. Afferent receptors in the airways and cough. Respir. Physiol. 114, 5–15 (1998).
Zygmunt, P. M., Julius, I., Di Marzo, V. & Hogestatt, E. D. Anandamide—the other side of the coin. Trends Pharmacol. Sci. 21, 43–44 (2000).
Ishac, E. J. et al. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol. 118, 2023–2028 (1996).
Coutts, A. A., Pertwee, R. G., Fernando, S. R. & Nash, J. E. Inhibition by cannabinoid receptor agonists of acetylcholine release from guinea-pig myenteric plexus. Br. J. Pharmacol. 121, 1557–1566 (1997).
Richardson, J. D., Kilo, S. & Hargreaves, K. M. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75, 111–119 (1998).
Katona, I. et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19, 4544–4558 (1999).
Rice, W., Shannon, J. M., Burton, F. & Fiedeldey, D. Expression of a brain-type cannabinoid receptor (CB1) in alveolar type II cells in the lung: regulation by hydrocortisone. Eur. J. Pharmacol. 327, 227–232 ( 1997).
Landsman, R. S., Burkey, T. H., Consroe, P., Roeske, W. R. & Yamamura, H. I. SR141716A is an inverse agonist at the human cannabinoid CB1 receptor. Eur. J. Pharmacol. 334, R1–R2 (1997).
Sugiura, T. et al. Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Eur. J. Biochem. 240, 53–62 (1996).
Cadas, H., di Tomaso, E. & Piomelli, D. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. 17, 1226–1242 (1997).
Van Hoozen, B. E. & Cross, C. E. Marijuana. Respiratory tract effects. Clin. Rev. Allergy Immunol. 15, 243–269 (1997).
Piomelli, D., Giuffrida, A., Calignano, A. & Rodríguez de Fonseca, F. The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol. Sci. 21, 218– 224 (2000).
Bolster, D. C., Del Prado, M., O'Reilly, S., Mingo, G. & Hey, J. A. Evan's blue dye blocks capsaicin-induced cough and bronchospasm in the guinea pig. Eur. J. Pharmacol. 276, R1–R3 (1995).
Samhoun, M. N. & Piper, P. J. The combined use of isolated strips of guinea-pig lung parenchyma and ileum as a sensitive and selective bioassay for leukotriene B4. Prostaglandins 27, 711–724 ( 1984).
Csiffary, A., Gorcs, T. J. & Palkovits, M. Neuropeptide Y innervation of ACTH-immunoreactive neurons in the arcuate nucleus of rats: a correlated light and electron microscopic double immunolabeling study. Brain Res. 506, 215–222 (1990).
Désarnaud, F., Cadas, H. & Piomelli, D. Anandamide amidohydrolase activity in rat brain microsomes: Identification and partial characterization. J. Biol. Chem. 270, 6030–6035 (1995).
Giuffrida, A., Rodríguez de Fonseca, F. & Piomelli, D. Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Anal. Biochem. 280, 87–93 ( 2000).
Acknowledgements
We thank S. Chen, M. Elefante, G. Fabozzi, G. Goda, E. Oswáld and R. Russo for excellent experimental assistance; T. Dinh, H. Kim and F. Nava for reading the manuscript critically; and B. Vigh for discussion. This research was supported from the National Institute of Drug Abuse (D.P. and K.M.), by the Howard Hughes Medical Institute and OTKA (T.F.), and by MURST (A.C.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Calignano, A., Kátona, I., Désarnaud, F. et al. Bidirectional control of airway responsiveness by endogenous cannabinoids . Nature 408, 96–101 (2000). https://doi.org/10.1038/35040576
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/35040576
This article is cited by
-
Modulation of pulmonary immune function by inhaled cannabis products and consequences for lung disease
Respiratory Research (2023)
-
New insights into the mechanisms of anandamide-induced airway dilation placing its degradation enzyme, FAAH center stage. Commentary on: Simon A, von Einem T, Seidinger A, Matthey M, Bindila L, Wenzel D (2022) The endocannabinoid anandamide is an airway relaxant in health and disease. Nat Commun 13:6941
Pflügers Archiv - European Journal of Physiology (2023)
-
Δ9-Tetrahydrocannabinol Effects on Respiration and Heart Rate Across Route of Administration in Female and Male Mice
Cardiovascular Toxicology (2023)
-
The endocannabinoid anandamide is an airway relaxant in health and disease
Nature Communications (2022)
-
Cannabis and Lung Health: Does the Bad Outweigh the Good?
Pulmonary Therapy (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.